Acute pain management in symptomatic cholelithiasis

By -

 


Executive Summary

Cholelithiasis (gallstones) is a highly prevalent condition in developed countries, yet clinical practice currently lacks standardized protocols for managing the acute pain associated with it—specifically biliary colic. This briefing document synthesizes evidence from a comprehensive literature review of randomized controlled trials (RCTs), non-randomized trials, and meta-analyses over a 15-year period.

The core finding of this analysis is that Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) are the superior choice for the treatment of biliary colic. Not only do they provide rapid and effective pain relief, but they also significantly reduce the risk of disease progression into complications such as acute cholecystitis. When compared to traditional treatments like opioids (meperidine) or antispasmodics (hyoscine), NSAIDs demonstrate a longer duration of action, a lower requirement for rescue analgesia, and a more favorable side-effect profile.

Background and Clinical Context

Cholelithiasis represents a significant burden on healthcare systems in the United States, United Kingdom, and Europe.

  • Prevalence: The condition affects approximately 10% of the adult population and 20% of individuals aged 65 and older.

  • Demographics: It is twice as common in females as in males.

  • Presentation: Biliary colic is the primary presenting symptom in 75% to 80% of patients with symptomatic cholelithiasis.

Despite the frequency of these cases, there is currently no universal protocol for acute pain management, leading to variations in practice across different medical centers.

Comparative Analysis of Analgesic Efficacy

The following table summarizes key studies and their outcomes regarding the pharmacological management of biliary colic:

Summary of Clinical Studies

Major Themes and Evidence

1. Superiority of NSAIDs Over Opioids and Antispasmodics

Evidence consistently indicates that NSAIDs, such as diclofenac and ketorolac, are more effective than traditional alternatives:

  • Side Effect Profile: Studies by Dula et al. and Henderson et al. found that while ketorolac and meperidine have similar analgesic efficacy, meperidine is associated with higher incidences of nausea and dizziness.

  • Speed of Action: Kumar et al. demonstrated that intramuscular diclofenac provides more rapid pain relief than hyoscine-N-butyl bromide, with over 90% of patients symptom-free within four hours.

  • Duration: NSAIDs offer a longer duration of action and require fewer doses compared to other analgesic agents.

2. Prevention of Complications

A critical finding is that NSAID administration influences disease progression, not just symptom management.

  • Reduction in Sequelae: In the study by Akriviadis et al., nearly 50% of the placebo group progressed to acute cholecystitis, whereas the diclofenac group showed significantly lower rates of complication.

  • Prognostic Improvement: The meta-analysis by Basurto Oña et al. (Level-I evidence) confirmed that NSAIDs lead to a lower need for rescue analgesia and a reduced risk of progression to serious complications (OR = 0.19).

3. Alternative and Adjunctive Therapies

  • Ursodeoxycholic Acid (UDCA): Long-term UDCA therapy (600 mg/d) is identified as a safe option for symptomatic patients who are at high surgical risk, as it reduces the likelihood of biliary pain and the eventual conversion to surgery.

  • Inefficacy of Anticholinergics: Glycopyrrolate failed to demonstrate significant pain relief compared to placebo, suggesting that anticholinergic agents may not be suitable for the treatment of biliary colic.

Conclusion

The literature provides robust evidence (Level-I) supporting the use of NSAIDs as the first-line treatment for biliary colic. They are characterized by:

  • Safe and effective pain control.

  • Pharmacological superiority (longer action, fewer side effects).

  • Preventative benefits regarding the development of cholelithiasis-related complications.

Current research suggests a need for multi-centric studies to understand the existing variations in clinical practice and to establish strict, evidence-based guidelines for prescribing analgesia in cases of biliary colic.